We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Pharmaceutical researchers at the University of Maryland are set to evaluate how well drugmakers respond to and process adverse event reports during manufacturing, according to a grant announcement from the School of Pharmacy’s Center on Drugs and Public Policy.